Skip to main content

Table 1 Patient characteristics

From: Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation

Patient number

Age (years)

Diagnosis

Days in ICU at study start

SOFA at study start

1

58

Medical

13

14

2

56

Surgical

6

15

3

79

Medical

2

13

4

39

Medical

17

7

5

75

Medical

8

12

6

68

Neurological

2

6

7

69

Surgical

8

11

8

76

Surgical

2

11

9

84

Surgical

4

11

10

74

Medical

1

12

11

51

Medical

6

10

  1. Patients 1 to 6 were randomized to measure in the fed state at baseline (control), before being fed and glutamine supplemented, patients 7 to 12 were randomized to measure in the fed state and glutamine supplemented before feeding at baseline (control). SOFA, sequential organ failure assessment.